FDA Clearance Tracker · P110006
SOMO.V ABUS (AUTOMATED BREAST ULTRASOUND SYSTEM)
Last checked: Nov 20, 2026Latest source record: Sep 18, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Sep 18, 2012
Approved
Time to decision
585 days
Received Feb 11, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P110006
- Device name
- SOMO.V ABUS (AUTOMATED BREAST ULTRASOUND SYSTEM)
- Applicant
- GE Healthcare
- Applicant location
- Wauwatosa, WI
- Received
- Feb 11, 2011
- Decided
- Sep 18, 2012
- Decision
- Approved
- Supplements
- 11 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Automated breast ultrasound (PAA)
- Device class
- Class III
- Specialty
- Radiology & Imaging
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE SOMO-V: AUTOMATED BREAST ULTRASOUND SYSTEM (ABUS). THIS DEVICE IS INDICATED AS AN ADJUNCT TO MAMMOGRAPHY FOR BREAST CANCER SCREENING IN ASYMPTOMATIC WOMEN FOR WHOM SCREENINGMAMMOGRAPHY FINDINGS ARE NORMAL OR BENIGN (BI-RADS ASSESSMENT CATEGORY 1 OR 2), WITH DENSE BREAST PARENCHYMA (BI-RADS COMPOSITION/DENSITY 3 OR 4) AND HAVE NOT HAD PREVIOUS CLINICALBREAST INTERVENTION. THE DEVICE IS INTENDED TO INCREASE BREAST CANCER DETECTION IN THE DESCRIBED PATIENT POPULATION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PAA (Automated breast ultrasound).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for GE Healthcare
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260656 · Decided Sep 1, 2026 · 186 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.